Physicians’ Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer

Abstract

A.C Wong, S Stock, D Schrag, K.L Kahn, T Salz, M.E Charlton, S.O Rogers, N.L Keating and K.A Goodman

International journal of radiation oncology, biology, physics, Vol.90(1), pp.S590-S590

09/01/2014

DOI: 10.1016/j.ijrobp.2014.05.1773

View Online

Title: Subtitle: Physicians’ Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer
Creators: A.C Wong - University of Chicago, Chicago, IL
S Stock - College of the Holy Cross, Worcester, MA
D Schrag - Dana-Farber Cancer Institute, Boston, MA
K.L Kahn - RAND and University of California at Los Angeles, Los Angeles, CA
T Salz - Memorial Sloan-Kettering Cancer Center, New York, NY
M.E Charlton - University of Iowa and Iowa City Veterans Affairs Medical Center, Iowa City, IA
S.O Rogers - Temple University School of Medicine, Philadelphia, PA
N.L Keating - Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
K.A Goodman - Memorial Sloan-Kettering Cancer Center, New York, NY
Resource Type: Abstract
Publication Details: International journal of radiation oncology, biology, physics, Vol.90(1), pp.S590-S590
Publisher: Elsevier Inc
DOI: 10.1016/j.ijrobp.2014.05.1773
ISSN: 0360-3016
eISSN: 1879-355X
Language: English
Date published: 09/01/2014
Academic Unit: Epidemiology
Record Identifier: 9984214830102771

1 Record Views